Odyssey Therapeutics, Inc. (ODTX)
NASDAQ: ODTX · Real-Time Price · USD
17.61
+0.55 (3.22%)
Jul 17, 2026, 4:00 PM EDT - Market closed
Odyssey Therapeutics Employees
Odyssey Therapeutics had 100 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
100
Change
n/a
Growth
n/a
Revenue / Employee
$10,580
Profits / Employee
-$1,484,740
Market Cap
843.13M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 100 | 0 | - |
| Dec 31, 2025 | 100 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 465 |
| Phathom Pharmaceuticals | 371 |
| DBV Technologies | 161 |
| Solid Biosciences | 121 |
| Theravance Biopharma | 90 |
| Aclaris Therapeutics | 73 |
| CytomX Therapeutics | 69 |
| Design Therapeutics | 54 |
ODTX News
- 24 days ago - Odyssey Therapeutics Slides: Corporate presentation - Filings
- 4 weeks ago - Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - Odyssey Therapeutics Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Odyssey Therapeutics Earnings release: Q1 2026 - Filings
- 6 weeks ago - Wedbush bullish on Odyssey Therapeutics, initiates with an Outperform - TheFly
- 6 weeks ago - Wedbush bullish on Odyssey Therapeutics, initiates with an Outperform - TheFly
- 6 weeks ago - Odyssey Therapeutics initiated with an Outperform at Wedbush - TheFly
- 6 weeks ago - Odyssey Therapeutics initiated with an Outperform at Oppenheimer - TheFly